Novel Sigma-1 receptor agonist alleviates renal ischemic injury by targeting apoptotic and inflammatory pathways.
- DOI
- 10.1038/s41598-025-23459-0
- Published
- 2025 Nov 13
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-025-23459-0,
title = {Novel Sigma-1 receptor agonist alleviates renal ischemic injury by targeting apoptotic and inflammatory pathways.},
author = {Toth AR and Lakat T and Budai A and Kallay H and Szokol B and Wagner LJ and Orfi L and Kreko M and Szabo AJ and Fekete A and Hosszu A},
year = {2025},
journal = {Scientific reports},
doi = {10.1038/s41598-025-23459-0},
url = {https://doi.org/10.1038/s41598-025-23459-0}
}RIS
TY - JOUR TI - Novel Sigma-1 receptor agonist alleviates renal ischemic injury by targeting apoptotic and inflammatory pathways. AU - Toth AR AU - Lakat T AU - Budai A AU - Kallay H AU - Szokol B AU - Wagner LJ AU - Orfi L AU - Kreko M AU - Szabo AJ AU - Fekete A AU - Hosszu A PY - 2025 JO - Scientific reports DO - 10.1038/s41598-025-23459-0 UR - https://doi.org/10.1038/s41598-025-23459-0 ER -
APA
AR, T., T, L., A, B., H, K., B, S., LJ, W., L, O., M, K., AJ, S., A, F., & A, H. (2025). Novel Sigma-1 receptor agonist alleviates renal ischemic injury by targeting apoptotic and inflammatory pathways.. Scientific reports. https://doi.org/10.1038/s41598-025-23459-0
Source records
- pubmed · retrieved 2026-09-27T09:11:15.920Z